Applying new technologies in chronic obstructive pulmonary disease (COPD)

Completed

• Conditions: Chronic obstructive pulmonary disease (COPD); Respiratory; Other chronic obstructive pulmonary disease

• Registration Number: ISRCTN82911859
• Lead Sponsor: Hywel Dda Health Board (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-06-25
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Patients (aged 40 - 90 years, either sex) with a diagnosis of COPD, according to Global initiative for chronic Obstructive Lung Disease (GOLD)
2. Healthy controls with no symptoms of COPD and no evidence of airflow obstruction on spirometry

Exclusion Criteria

1. Patients unable or unwilling to give informed consent
2. Those with a current or previous diagnosis of cancer
3. Those with known co-existent asthma, bronchiectasis or pulmonary fibrosis, severe heart failure (ejection fraction [EF] less than 35% on echocardiogram or chronic renal failure - estimated glomerular filtration rate [eGFR] less than 60/ml/min/1.73 m^2)
4. Currently suffering an exacerbation (at enrolment)

Study & Design

• Study Type: Observational
• Study Design: Not specified